Sagimet Biosciences Inc. Series A Common Stock (SGMT) — Long-term Investment Intensity
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a Long-term Investment Intensity of 6.6% as of June 2026. Long-term investments of $17.44 Million represent 6.6% of total assets of $263.43 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Sagimet Biosciences Inc. Series A Common's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sagimet Biosciences Inc. Series A Common Stock Long-term Investment Intensity (2024–2024)
This chart shows how Sagimet Biosciences Inc. Series A Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of June 2026, the intensity stands at 6.6%, reflecting long-term investments of $17.44 Million against total assets of $263.43 Million USD. For the complete balance sheet picture, see total assets of Sagimet Biosciences Inc. Series A Common.
Annual Long-term Investment Intensity for Sagimet Biosciences Inc. Series A Common Stock (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Sagimet Biosciences Inc. Series A Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Sagimet Biosciences Inc. Series A Common (SGMT) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 4.6% | $7.41 Million | $160.26 Million | — |